MLICM
KRRO icon

Metropolitan Life Insurance Company (MetLife)’s Korro Bio KRRO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-111
Closed -$52.7K – 2797
2021
Q1 		$52.7K Sell
111
-31
-22% -$60.2K ﹤0.01% 2533
2020
Q4 		$250K Sell
142
-38
-21% -$50.2K ﹤0.01% 1791
2020
Q3 		$173K Hold
180
– – ﹤0.01% 1868
2020
Q2 		$209K Buy
+180
New +$163K ﹤0.01% 1763

Other funds holding KRRO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s KRRO Position: Q2 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Korro Bio (KRRO) in Q2 2021, closing a stake of 111 shares — an estimated $52.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in KRRO in Q2 2020 and held it in 4 quarters. The position peaked at $250K in Q4 2020. 91 funds tracked by Wall St. Rank hold KRRO as of Q2 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Korro Bio position as of Q2 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 111 Korro Bio shares in Q2 2021, an estimated $52.7K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Korro Bio in Q2 2020 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Korro Bio position peaked at $250K in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Korro Bio as of Q2 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.